Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03936465
Title Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitor BMS-986158 in Pediatric Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

NUT midline carcinoma

Advanced Solid Tumor

lymphoma

central nervous system cancer

Therapies

BMS986158

CC-90010

Age Groups: child | adult
Covered Countries USA | CAN


No variant requirements are available.